In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers
David S. Alberts, Paul T. Fanta, Kelli L. Running, Laurence P. Adair, Dava J. Garcia, Rosa Liu-Stevens, Sydney E. Salmon
Fingerprint
Dive into the research topics of 'In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers'. Together they form a unique fingerprint.